Company Analysis

CervoMed Inc. (CRVO)

Nasdaq: CRVO · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 1998
Grade4.3
◀ Past 2.7● Present 4.4▶ Future 5.1
2 est.

Who runs CervoMed Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Alam John J
CEO & President. First filing Aug 2023, latest Jun 10, 2026, 3 filings in all.
Officers reporting now
5
of 12 people with a filing in the last fifteen months
Directors reporting now
7
30 people on the record since 2011
Officerssales are open-market, Oct 23, 2025 to Oct 23, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Winton MatthewChief Commercial and BusinessOct 2025Oct 23, 2026none
Blackburn KellyEVP, Clinical DevelopmentAug 2023Oct 23, 2026none
De Rosch MarkEVP, RA and GA and PgMMay 2025Oct 23, 2026none
Alam John JCEO & PresidentAug 2023Jun 10, 2026none
Elder William RobertCFO, GC & SecretaryOct 2020Feb 13, 2026none
Directorssales are open-market, Oct 23, 2025 to Oct 23, 2026
NameRoleFirst filingLatest filingSales, 12 months
Boger Joshua SdirectorFeb 2024Jun 15, 2026none
Gregoire SylviedirectorAug 2023Jun 10, 2026none
Hollingsworth Jane HdirectorOct 2020Jun 10, 2026none
Poulton Jeffrey V.directorAug 2023Jun 10, 2026none
Quigley DaviddirectorDec 2025Jun 10, 2026none
Sabbagh MarwandirectorAug 2023Jun 10, 2026none
Zavrl FrankdirectorAug 2023Jun 10, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRVO · research, not advice